Susquehanna International Group, LLP Supernus Pharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 20,074 shares of SUPN stock, worth $714,032. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,074

Previous 12,402 61.86%

Holding current value

$714,032

Previous $331,000 88.82%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$25.77 - $35.16 $197,707 - $269,747	7,672 Added 61.86%	20,074 $625,000
Q2 2024 Aug 15, 2024	BUY	$25.99 - $33.85 $156,901 - $204,352	6,037 Added 94.85%	12,402 $331,000
Q1 2024 May 07, 2024	SELL	$27.11 - $35.17 $267,385 - $346,881	-9,863 Reduced 60.78%	6,365 $217,000
Q4 2023 Feb 14, 2024	SELL	$22.72 - $29.68 $466,873 - $609,894	-20,549 Reduced 55.87%	16,228 $469,000
Q3 2023 Nov 14, 2023	SELL	$27.57 - $32.91 $272,832 - $325,677	-9,896 Reduced 21.2%	36,777 $1.01 Million
Q2 2023 Aug 11, 2023	BUY	$29.91 - $38.73 $34,007 - $44,036	1,137 Added 2.5%	46,673 $1.4 Million
Q1 2023 May 16, 2023	BUY	$34.93 - $42.03 $1.59 Million - $1.91 Million	45,536 New	45,536 $1.65 Million
Q3 2022 Nov 14, 2022	BUY	$28.79 - $35.41 $482,030 - $592,869	16,743 New	16,743 $567,000
Q4 2021 Feb 14, 2022	BUY	$26.37 - $34.22 $249,249 - $323,447	9,452 Added 50.36%	28,220 $823,000
Q3 2021 Nov 15, 2021	BUY	$23.54 - $31.39 $187,543 - $250,084	7,967 Added 73.76%	18,768 $501,000
Q2 2021 Aug 11, 2021	SELL	$26.72 - $33.19 $983,483 - $1.22 Million	-36,807 Reduced 77.31%	10,801 $333,000
Q1 2021 May 17, 2021	BUY	$24.15 - $31.45 $191,509 - $249,398	7,930 Added 19.99%	47,608 $1.25 Million
Q4 2020 Feb 16, 2021	BUY	$17.7 - $25.81 $469,740 - $684,971	26,539 Added 201.99%	39,678 $998,000
Q3 2020 Nov 16, 2020	SELL	$20.2 - $25.05 $317,443 - $393,660	-15,715 Reduced 54.46%	13,139 $274,000
Q2 2020 Aug 14, 2020	BUY	$17.09 - $24.89 $204,584 - $297,958	11,971 Added 70.91%	28,854 $685,000
Q1 2020 May 15, 2020	SELL	$14.45 - $24.69 $483,309 - $825,806	-33,447 Reduced 66.46%	16,883 $304,000
Q4 2019 Feb 14, 2020	SELL	$19.93 - $29.13 $1.58 Million - $2.3 Million	-79,057 Reduced 61.1%	50,330 $1.19 Million
Q3 2019 Nov 14, 2019	BUY	$25.47 - $33.37 $1.05 Million - $1.37 Million	41,037 Added 46.45%	129,387 $3.56 Million
Q2 2019 Aug 16, 2019	BUY	$29.96 - $38.87 $235,755 - $305,868	7,869 Added 9.78%	88,350 $2.92 Million
Q2 2019 Aug 14, 2019	BUY	$29.96 - $38.87 $1.87 Million - $2.43 Million	62,436 Added 346.0%	80,481 $2.66 Million
Q1 2019 May 15, 2019	SELL	$32.77 - $41.99 $3.28 Million - $4.2 Million	-100,126 Reduced 84.73%	18,045 $632,000
Q4 2018 Feb 14, 2019	BUY	$30.84 - $49.51 $3.23 Million - $5.19 Million	104,792 Added 783.26%	118,171 $3.93 Million
Q3 2018 Nov 14, 2018	SELL	$42.7 - $56.55 $20,538 - $27,200	-481 Reduced 3.47%	13,379 $674,000
Q2 2018 Aug 14, 2018	SELL	$44.1 - $59.85 $1.51 Million - $2.05 Million	-34,331 Reduced 71.24%	13,860 $830,000
Q4 2017 Feb 14, 2018	SELL	$36.4 - $42.6 $1.92 Million - $2.25 Million	-52,746 Reduced 52.26%	48,191 $1.92 Million
Q3 2017 Nov 14, 2017	BUY	$36.75 - $49.65 $3.71 Million - $5.01 Million	100,937	100,937 $4.04 Million

Others Institutions Holding SUPN

# of Institutions

282

Shares Held

61.1M

Call Options Held

27.7K

Put Options Held

11.3K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.9B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Supernus Pharmaceuticals, Inc. Transaction History